Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca    AZN   GB0009895292

ASTRAZENECA (AZN)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

AstraZeneca Buys Back 318283 Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/30/2012 | 12:23pm CEST

AstraZeneca PLC (>> AstraZeneca plc) said Monday it has purchased 318,283 ordinary shares on April 27 at a price of 2666 pence per share for cancellation.

-Shares at 1005 GMT up 1%, at 2704 pence, valuing the company at GBP34 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; mark.shapland@dowjones.com

Stocks mentioned in the article : AstraZeneca plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASTRAZENECA
08/14 Big-name U.S. hedge funds shed healthcare stocks during the rally in second-q..
08/14 Big-name U.S. hedge funds shed healthcare stocks during the rally in second q..
08/11 PFIZER : attempting to develop therapies for pancreatic cancer have failed
08/11 PIERIS PHARMACEUTICALS : Reports Financial Results for the Second Quarter Ended ..
08/10 Income investors run for cover as dependable UK dividends in jeopardy
08/10 Worst day in four months for FTSE as ex-divs, housebuilders weigh
08/10 ASTRAZENECA : Reports Summarize Science Findings from AstraZeneca (Mass Spectrom..
08/10 PFIZER : Fake cancer drugs hit Uganda market
08/10 ASTRAZENECA PLC : ex-dividend day for interim dividend
08/08 ASTRAZENECA : seeks Japan's first approval for hereditary cancer drug in relapse..
More news
News from SeekingAlpha
08/16 3 THINGS IN BIOTECH YOU SHOULD LEARN : August 17, 2017
08/11 STARPHARMA : At Last It Is Happening
08/09 ProLung Files For $8 Million Mini-IPO
08/09 Dermira Grabs Big Pharma Castoff
08/09 3 THINGS IN BIOTECH YOU SHOULD LEARN : August 9, 2017
Financials ($)
Sales 2017 21 584 M
EBIT 2017 5 714 M
Net income 2017 2 629 M
Debt 2017 12 527 M
Yield 2017 4,73%
P/E ratio 2017 26,01
P/E ratio 2018 22,04
EV / Sales 2017 3,95x
EV / Sales 2018 3,93x
Capitalization 72 774 M
Chart ASTRAZENECA
Duration : Period :
AstraZeneca Technical Analysis Chart | AZN | GB0009895292 | 4-Traders
Technical analysis trends ASTRAZENECA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 34
Average target price 62,9 $
Spread / Average Target 9,2%
EPS Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Dunoyer Chief Financial Officer & Executive Director
Sean Bohen Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA0.68%72 774
JOHNSON & JOHNSON15.77%357 992
NOVARTIS10.12%219 731
ROCHE HOLDING LTD.5.33%217 452
PFIZER2.71%198 782
MERCK AND COMPANY6.51%170 460